Burning Rock Biotech LTD Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
Kynam Capital Management, LP and Yue Tang have filed an amendment reporting a 13.97% beneficial ownership stake in Burning Rock Biotech Ltd.
NASDAQ
CRCM Institutional Master Fund and associated entities have filed a Schedule 13G reporting a 3.2% beneficial ownership stake in Burning Rock Biotech Ltd.
NASDAQ
CRCM Institutional Master Fund, CRCM LP, CRCM LLC, and Chun R. Ding have jointly disclosed beneficial ownership of 5.38% of Burning Rock Biotech Ltd.'s American Depository Shares.
NASDAQ
Kynam Capital Management, LP, Kynam Capital Management GP, LLC, and Yue Tang collectively reported beneficial ownership of 11.01% of Burning Rock Biotech Ltd's American Depository Shares.